Bank of Montreal
OBIO icon

Bank of Montreal’s Orchestra BioMed OBIO Stock Holding History

Bank of Montreal’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-200,000
Closed -$1.99K – 4322
2022
Q2 		$1.99K Hold
200,000
– – ﹤0.01% 1890
2022
Q1 		$1.99M Buy
200,000
+50,000
+33% +$494K ﹤0.01% 1939
2021
Q4 		$1.48M Buy
+150,000
New +$1.48M ﹤0.01% 1751

Other funds holding OBIO

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Bank of Montreal's OBIO Position: Q3 2022 in Review

Bank of Montreal sold out of Orchestra BioMed (OBIO) in Q3 2022, closing a stake of 200,000 shares — an estimated $1.99K sold.

Bank of Montreal first reported a position in OBIO in Q4 2021 and held it in 3 quarters. The position peaked at $1.99M in Q1 2022. 23 funds tracked by Wall St. Rank hold OBIO as of Q3 2022.

  • Bank of Montreal reported no remaining Orchestra BioMed position as of Q3 2022 after selling out during the quarter.
  • Bank of Montreal sold 200,000 Orchestra BioMed shares in Q3 2022, an estimated $1.99K.
  • Bank of Montreal first reported a position in Orchestra BioMed in Q4 2021 and held it in 3 quarters.
  • Bank of Montreal's Orchestra BioMed position peaked at $1.99M in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.